The FDA has accepted an investigational new drug application for ALLO-329, an allogeneic chimeric antigen receptor T-cell ...

What’s the full story? Seaport lays out a bullish case, starting with the massive total addressable market for groceries, ...

Cabaletta Bio (CABA) announced new and updated clinical data from the first 10 patients dosed with resecabtagene autoleucel, or rese-cel, ...

Allogene Therapeutics, Inc. (NASDAQ:ALLO), a biotechnology company specializing in the development of allogeneic CAR T cell therapies, stands at a critical juncture in its journey to bring innovative ...

CRISPR Therapeutics (CRSP) stock slips after a strong rally driven by earnings beats and analyst upgrades. Explore future catalysts and investment insights.

Feb. 8, 2024 — Researchers have discovered a previously unknown ability of a group of immune system cells, known as Atypical B cells (ABCs ... Lupus Erythematosus (SLE): New Genetic Findings ...

PHILADELPHIA, PA — Cabaletta Bio, Inc. (Nasdaq: CABA) shared new and updated results from its RESET clinical development ...

This project has not set up a SECURITY.md file yet.

Nguyen Thi Ngoc Lan, 31, and her husband Adrian Ching Kah Siang, 36, were each given a three-week jail sentence.

University of Pittsburgh School of Medicine and UPMC Hillman Cancer Center scientists have discovered a novel subset of ...